Clinical Trial: Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07627568) titled 'Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.' on May 30.

Brief Summary: The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.

Study Start Date: May 30

Study Type: OBSERVATIONAL

Condition: AML With NPM1 Mutations or KMT2A Rearrangements

Recruitment Status: RECRUITING

Sponsor: University of Freiburg

Information provided by (Responsible Party): Robert Zeiser, University of Freib...